Skip to content
Skip to main navigation
Skip to first column
Skip to second column
Neurometabolic Diseases Lab
Home
Lines of Research
Publications
Publications
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
Hits
1
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
24
2
Case Report: Benign Infantile Seizures Temporally Associated With COVID-19.
42
3
Ceramide signalling in inherited and multifactorial brain metabolic diseases.
36
4
Improved Diagnosis of Rare Disease Patients through Systematic Detection of Runs of Homozygosity.
45
5
High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.
42
6
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
43
7
HNRNPH1-related Syndromic Intellectual Disability: Seven Additional Cases Suggestive of a Distinct Syndromic Neurodevelopmental Syndrome
73
8
Phenotypic Correlations in a Large Single Center Cohort of Patients With BSCL2 Nerve Disorders: A Clinical, Neurophysiological and Muscle MRI Study
79
9
The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
67
10
A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases.
60
11
POLR3A variants with striatal involvement and extrapyramidal movement disorder.
53
12
Truncating variants in UBAP1 associated with childhood-onset nonsyndromic hereditary spastic paraplegia.
68
13
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism.
59
14
Clinical presentation and proteomic signature of patients with TANGO2 mutations.
68
15
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.
181
16
A novel mutation in the GFAP gene expands the phenotype of Alexander disease.
162
17
FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.
183
18
Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.
213
19
Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
240
20
SIRT2 in age-related neurodegenerative disorders
208
«
Start
Prev
1
2
3
4
5
Next
End
»
Page 1 of 5
Main Menu
Home
Lines of Research
Publications
Highlighted publications
Databases
Staff
Collaborations
Job opportunities
On the News
Web Links
Contact
View My Stats